There is no significant increase in the incidence of Helicobacter pylori infection in patients with inflammatory bowel disease in turkey [3]

Journal of Clinical Gastroenterology

Volumn 33, Issue 1, 2001, Pages 87-88

  Parlak, E ^a   Ulker A ^a   Disibeyaz S ^a   Alkim, C ^a   Dagli U ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; SALAZOSULFAPYRIDINE;

ADULT; AGE; CONTROLLED STUDY; CROHN DISEASE; DEVELOPING COUNTRY; ENTERITIS; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TURKEY (REPUBLIC); ULCERATIVE COLITIS;

ADULT; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; TURKEY;

EID: 0034964248     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200107000-00025     Document Type: Letter

References (4)

1. Low prevalence of Helicobacter pylori in inflammatory bowel disease: Association with sulphasalazine
2. Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease
3. Prevalence of upper gastrointestinal lesions and Helicobacter pylori infection in Crohn's disease
4. Appendectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: A case control study